ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

ASCO Releases Guideline On Larynx Preservation

July 28, 2006

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

Sole Source Negotiations

March 7, 1975

Anti-NCI Forces Fail to Raid $70 Million from Cancer Program

September 26, 1975

Scientific Opportunity Should Guide Fund Allocation, House Says

August 4, 1995

Also in this 12-page issue: ASCO urges freeze of Medicare payments for chemotherapy at 2004 levels for next two years.

February 20, 2004